Source: Pharmaceuticals. Unidades: FFCLRP, FEARP, FMRP
Subjects: OSTEOSSARCOMA, BIOMARCADORES, EXPRESSÃO GÊNICA, TRANSCRIÇÃO GÊNICA
ABNT
MEDEIROS, Mariana et al. Amicis omnia sunt communia: NF-κB inhibition as an alternative to overcome osteosarcoma heterogeneity. Pharmaceuticals, v. 17, n. 6, p. 1-33, 2024Tradução . . Disponível em: https://doi.org/doi.org/10.3390/ph17060734. Acesso em: 14 maio 2025.APA
Medeiros, M., Guenka, S., Bastos, D., Oliveira, K. L., & Brassesco, M. S. (2024). Amicis omnia sunt communia: NF-κB inhibition as an alternative to overcome osteosarcoma heterogeneity. Pharmaceuticals, 17( 6), 1-33. doi:doi.org/10.3390/ph17060734NLM
Medeiros M, Guenka S, Bastos D, Oliveira KL, Brassesco MS. Amicis omnia sunt communia: NF-κB inhibition as an alternative to overcome osteosarcoma heterogeneity [Internet]. Pharmaceuticals. 2024 ; 17( 6): 1-33.[citado 2025 maio 14 ] Available from: https://doi.org/doi.org/10.3390/ph17060734Vancouver
Medeiros M, Guenka S, Bastos D, Oliveira KL, Brassesco MS. Amicis omnia sunt communia: NF-κB inhibition as an alternative to overcome osteosarcoma heterogeneity [Internet]. Pharmaceuticals. 2024 ; 17( 6): 1-33.[citado 2025 maio 14 ] Available from: https://doi.org/doi.org/10.3390/ph17060734